Business Segment (Details) - Schedule of Business Segment - Other Operating Segment [Member] - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Schedule of Business Segment [Line Items]
Revenues		$ 145	$ 511
Losses		(26,451)	(95,255)
FOXO Labs [Member]
Schedule of Business Segment [Line Items]
Revenues	[1]	126	483
Losses	[1]	(2,149)	(2,769)
FOXO Life [Member]
Schedule of Business Segment [Line Items]
Revenues		19	28
Losses		(1,645)	(3,735)
FOXO Technologies Inc [Member]
Schedule of Business Segment [Line Items]
Revenues		145	511
Losses		(3,794)	(6,504)
Corporate and other [Member]
Schedule of Business Segment [Line Items]
Revenues	[2]
Losses	[2]	(21,593)	(87,311)
Interest expense [Member]
Schedule of Business Segment [Line Items]
Revenues
Losses		$ (1,064)	$ (1,440)

[1] (a)For 2023, FOXO Labs losses include $1,313 for the write off of supplies.

[2] For 2023, Corporate and other includes stock-based compensation, including amortization of consulting fees paid in stock, of $2,586, depreciation and amortization expense of $1,279, impairment charges of $2,633, change in fair value of warrant liability of $303, loss from PIK Note Amendment and 2022 Debenture Release of $3,521 and $19 of other income, net. For 2022, Corporate and other includes stock-based compensation, including the consulting agreement, Cantor Commitment Fee and vendor shares expense of $17,708, depreciation and amortization expense of $1,487, change in fair value of convertible debentures and warrant liability expense of $26,104, $1,307 for impairment charge and $27,544 of other non-operating expenses. See Notes 5, 6, 7, 9 and 11 for additional information.